Nancy C. Andrews
At a glance: Nancy C. Andrews is Director at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Aug 20, 2026, reported a sale of $163K. On file: 0 purchase lines ($0) and 1 sale line ($163K).
Disclosed holdings: about $452K of CRL stock: 1,438 shares reported on their latest Form 4 (filed Aug 20, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Charles River Laboratories International, Inc. (CRL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 20SEC | CRLCharles River Laboratories International, Inc. | Sell | 5731,438 held (−28%) | $285.24 | $163K | +10.2% |
- Sell
Director Nancy C Andrews sold $163K of CRL at $285.24 — cuts the stake by 28%.
Follow Nancy C. Andrews
Get one email when Nancy C. Andrews files a new purchase or sale. Free.
At most one email a day about Nancy C. Andrews, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.